Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002050471-25-000001
Filing Date
2025-02-13
Accepted
2025-02-13 10:26:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 7035
2 EXHIBIT 99.1: JOINT FILING AGREEMENT Exhibit_99_Melani_Velocity.pdf EX-99.1: JT FILING 105626
  Complete submission text file 0002050471-25-000001.txt   154255
Mailing Address 300 CONSHOHOCKEN STATE RD. SUITE 200 W. CONSHOHOCKEN PA 19428
Business Address 300 CONSHOHOCKEN STATE RD. SUITE 200 W. CONSHOHOCKEN PA 19428 610-540-7515
Medicus Pharma Ltd. (Subject) CIK: 0001997296 (see all company filings)

EIN.: 981778211 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94797 | Film No.: 25617917
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 KING ST W SUITE 3400 TORONTO Z4 M5X 1A4
Business Address
Melani Kenneth R. (Filed by) CIK: 0002050471 (see all company filings)

Type: SCHEDULE 13G